Loading
Latest filing published 09 Jan 2026 for SELLAS Life Sciences Group, Inc..
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Katherine Bach Kalin on record concern SELLAS Life Sciences Group, Inc. The record holds 6 filings, for trades running from 2 February 2023 to 7 January 2026.
On the market, this insider has only ever bought: 2 purchases, €119k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 4 share grants.
On 9 January 2026 came the latest disclosure, a share grant in SELLAS Life Sciences Group, Inc. The clock since the last published purchase (21 November 2025) now reads 337 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations